BACKGROUND
Myelofibrosis (MF) is a myeloid bone marrow malignancy with a progressive clinical course marked by disease-related symptoms, splenomegaly, cytopenias, thrombosis/hemorrhage, and a risk for blast phase transformation. Treatment recommendations are based on the burden of symptoms, prognosis of the disease, an...
B. Stein, Maya Abdallah, Gregory A. Abel et al.· Blood Advances· 0 citations
Invasive fungal infections (IFIs) cause substantial morbidity and mortality, yet optimal antifungal prophylaxis in adult acute lymphoblastic leukemia (ALL) remains uncertain given unclear incidence and drug interaction constraints. We performed a PRISMA 2020-compliant systematic review and meta-analysis (PROSPERO CRD42...
Christian M. Farag, Ann Mercurio, Rejowana Rouf et al.· Leukemia and Lymphoma· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.